# Ew2health

> Behavioral intelligence infrastructure for obesity care. Ew2health gives medical weight-loss clinics predictive analytics on GLP-1 adherence, dropout risk, and treatment effectiveness.

Ew2health combines patented Predictive Behavioral Analytics with a 3D biomarker model to forecast patient adherence and prevent dropout in GLP-1 and obesity programs. The platform is deployed in clinics across Brazil and the Netherlands, validated through partnerships including Mayo Clinic, and serves clinics, self-managed corporate health plans, and research collaborators.

## Pages

- [Home](/en): Predictive behavioral intelligence for medical weight-loss clinics.
- [About](/en/about): Company, mission, and team behind Ew2health.
- [Platform](/en/platform): Predictive Behavioral Analytics and the 3D biomarker model.
- [For Clinics](/en/for-clinics): How clinics use Ew2health to reduce GLP-1 dropout.
- [For Companies](/en/for-companies): Corporate obesity programs for self-managed health plans.
- [Calculator](/en/calculator): Estimate the revenue impact of GLP-1 patient dropout.
- [Insights](/en/insights): Essays and strategic briefs on behavioral intelligence in obesity care.
- [Investors](/en/investors): Seed-round opportunity and strategic case.
- [Book a demo](/en/book-demo): Schedule a clinic demo.
- [Contact](/en/contact): Get in touch with the Ew2health team.

## Optional

- [Dutch site](/nl)
- [Portuguese (Brazil) site](/pt-br)
- [Sitemap](/sitemap.xml)